Show simple item record

Baseline factors predicting change from the initial DMARD treatment during the first 2 years of rheumatoid arthritis : experience in the ERAN inception cohort

dc.contributor.authorMcWilliams, Daniel F.
dc.contributor.authorKiely, Patrick D. W.
dc.contributor.authorYoung, Adam
dc.contributor.authorWalsh, David A.
dc.date.accessioned2014-04-08T12:00:23Z
dc.date.available2014-04-08T12:00:23Z
dc.date.issued2013-05
dc.identifier.citationMcWilliams , D F , Kiely , P D W , Young , A & Walsh , D A 2013 , ' Baseline factors predicting change from the initial DMARD treatment during the first 2 years of rheumatoid arthritis : experience in the ERAN inception cohort ' , BMC Musculoskeletal Disorders , vol. 14 , 153 . https://doi.org/10.1186/1471-2474-14-153
dc.identifier.issn1471-2474
dc.identifier.otherPURE: 2929498
dc.identifier.otherPURE UUID: cbcc88fc-6bb2-493d-97a1-a31a40c12dd6
dc.identifier.otherPubMed: 23634781
dc.identifier.otherScopus: 84876806117
dc.identifier.urihttp://hdl.handle.net/2299/13304
dc.description© 2013 McWilliams et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
dc.description.abstractOutcomes in early Rheumatoid Arthritis (RA) may be improved by rapidly establishing a stable and effective disease modifying anti-rheumatic drug (DMARD) treatment regimen. We aimed to investigate whether baseline factors and initial treatment strategies are associated with changes to the first DMARD treatment, due to either Lack of Efficacy (LoE) or Adverse Drug Reaction (ADR) within 2 years of presentation.en
dc.format.extent7
dc.language.isoeng
dc.relation.ispartofBMC Musculoskeletal Disorders
dc.rightsOpen
dc.subjectAdult
dc.subjectAged
dc.subjectAntirheumatic Agents
dc.subjectArthritis, Rheumatoid
dc.subjectCohort Studies
dc.subjectDisability Evaluation
dc.subjectDrug Substitution
dc.subjectDrug Therapy, Combination
dc.subjectDrug-Related Side Effects and Adverse Reactions
dc.subjectFemale
dc.subjectHealth Status
dc.subjectHumans
dc.subjectHydroxychloroquine
dc.subjectLogistic Models
dc.subjectMale
dc.subjectMethotrexate
dc.subjectMiddle Aged
dc.subjectSulfasalazine
dc.subjectTreatment Failure
dc.subjectTreatment Outcome
dc.titleBaseline factors predicting change from the initial DMARD treatment during the first 2 years of rheumatoid arthritis : experience in the ERAN inception cohorten
dc.contributor.institutionSchool of Life and Medical Sciences
dc.contributor.institutionHealth & Human Sciences Research Institute
dc.contributor.institutionPostgraduate Medicine
dc.contributor.institutionHealth Services and Medicine
dc.contributor.institutionCentre for Postgraduate Medicine
dc.description.statusPeer reviewed
dc.relation.schoolSchool of Life and Medical Sciences
dc.description.versiontypeFinal Published version
dcterms.dateAccepted2013-05
rioxxterms.versionVoR
rioxxterms.versionofrecordhttps://doi.org/10.1186/1471-2474-14-153
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue
herts.rights.accesstypeOpen


Files in this item

Thumbnail
Name:
906781.pdf
Size:
319.7Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record